• DNAtrix, Valo Therapeutics Announce Partnership americanpharmaceuticalreview
    November 14, 2018
    DNAtrix and Valo Therapeutics announced an exclusive R&D collaboration to develop enhanced vaccines using DNAtrix's clinical stage viruses and Valo's proprietary antigenic peptide technology.
PharmaSources Customer Service